Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Circulating tumor cell-derived preclinical models: current status and future perspectives

Z. Kahounová, M. Pícková, S. Drápela, J. Bouchal, E. Szczyrbová, J. Navrátil, K. Souček

. 2023 ; 14 (8) : 530. [pub] 20230817

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016545

Despite the advancements made in the diagnosis and treatment of cancer, the stages associated with metastasis remain largely incurable and represent the primary cause of cancer-related deaths. The dissemination of cancer is facilitated by circulating tumor cells (CTCs), which originate from the primary tumor or metastatic sites and enter the bloodstream, subsequently spreading to distant parts of the body. CTCs have garnered significant attention in research due to their accessibility in peripheral blood, despite their low abundance. They are being extensively studied to gain a deeper understanding of the mechanisms underlying cancer dissemination and to identify effective therapeutic strategies for advanced stages of the disease. Therefore, substantial efforts have been directed towards establishing and characterizing relevant experimental models derived from CTCs, aiming to provide relevant tools for research. In this review, we provide an overview of recent progress in the establishment of preclinical CTC-derived models, such as CTC-derived xenografts (CDX) and cell cultures, which show promise for the study of CTCs. We discuss the advantages and limitations of these models and conclude by summarizing the potential future use of CTCs and CTC-derived models in cancer treatment decisions and their utility as precision medicine tools.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016545
003      
CZ-PrNML
005      
20240903093230.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41419-023-06059-6 $2 doi
035    __
$a (PubMed)37591867
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kahounová, Zuzana $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 612 00, Brno, Czech Republic
245    10
$a Circulating tumor cell-derived preclinical models: current status and future perspectives / $c Z. Kahounová, M. Pícková, S. Drápela, J. Bouchal, E. Szczyrbová, J. Navrátil, K. Souček
520    9_
$a Despite the advancements made in the diagnosis and treatment of cancer, the stages associated with metastasis remain largely incurable and represent the primary cause of cancer-related deaths. The dissemination of cancer is facilitated by circulating tumor cells (CTCs), which originate from the primary tumor or metastatic sites and enter the bloodstream, subsequently spreading to distant parts of the body. CTCs have garnered significant attention in research due to their accessibility in peripheral blood, despite their low abundance. They are being extensively studied to gain a deeper understanding of the mechanisms underlying cancer dissemination and to identify effective therapeutic strategies for advanced stages of the disease. Therefore, substantial efforts have been directed towards establishing and characterizing relevant experimental models derived from CTCs, aiming to provide relevant tools for research. In this review, we provide an overview of recent progress in the establishment of preclinical CTC-derived models, such as CTC-derived xenografts (CDX) and cell cultures, which show promise for the study of CTCs. We discuss the advantages and limitations of these models and conclude by summarizing the potential future use of CTCs and CTC-derived models in cancer treatment decisions and their utility as precision medicine tools.
650    _2
$a lidé $7 D006801
650    12
$a nádorové cirkulující buňky $7 D009360
650    _2
$a buněčné kultury $7 D018929
650    _2
$a heterografty $7 D064593
650    _2
$a individualizovaná medicína $7 D057285
650    _2
$a transplantace heterologní $7 D014183
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pícková, Markéta $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 612 00, Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, 602 00, Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00, Brno, Czech Republic
700    1_
$a Drápela, Stanislav $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 612 00, Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, 602 00, Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00, Brno, Czech Republic $u Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
700    1_
$a Bouchal, Jan $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital, 779 00, Olomouc, Czech Republic
700    1_
$a Szczyrbová, Eva $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital, 779 00, Olomouc, Czech Republic
700    1_
$a Navrátil, Jiří $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 656 53, Brno, Czech Republic $7 xx0164164
700    1_
$a Souček, Karel $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, 612 00, Brno, Czech Republic. ksoucek@ibp.cz $u International Clinical Research Center, St. Anne's University Hospital, 602 00, Brno, Czech Republic. ksoucek@ibp.cz $u Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00, Brno, Czech Republic. ksoucek@ibp.cz $1 https://orcid.org/0000000172838150
773    0_
$w MED00173233 $t Cell death & disease $x 2041-4889 $g Roč. 14, č. 8 (2023), s. 530
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37591867 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20240903093227 $b ABA008
999    __
$a ok $b bmc $g 2000203 $s 1202907
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 14 $c 8 $d 530 $e 20230817 $i 2041-4889 $m Cell death & disease $n Cell Death Dis $x MED00173233
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace